2018 set benchmark for digital health investment - report

Last year was the biggest ever for digital health investment, according to a report that has been tracking the market since the beginning of the decade.

PureTech's Vedanta raises $27m for microbiome research

US-based Vedanta Biosciences has raised $27 million in a Series C financing to investigate microbiome-derived therapies for several indications, including cancer and

Frontiers Health 2018 Live Day Two

Frontiers Health 2017 Live Blog - Day One coverage

The pharmaphorum team were on site and reporting live with all the key learnings and insights from Frontiers Health 2017.

UK charities plan billion-pound biotech fund

New company aims to boost UK biotech.

Nissan stays in UK - but will Japanese pharma?

Japanese R&D investment could follow EMA out of UK - experts.